Teva Pharma (TEVA) Sees Active Put Buying Ahead of Earnings Announcement Tomorrow BMC -Susquehanna
Tweet
Share
E-mail
Get Alerts TEVA Hot Sheet
Price: $34.65 -1.81%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.1%
Revenue Growth %: -3.6%
Join SI Premium – FREE
Susquehanna options strategist Alison Edwards notes protective or bearish activity in Teva Pharma (NYSE: TEVA), as investors purchased ~9000 June 30 Puts and ~2000 May12 30 Puts today, ahead of the company's earnings report tomorrow before the market open.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance
- MasTec to acquire The Superior Group for about $1.65 billion
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Susquehanna International Group of Companies, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
